THIS ASSAY IS USEFUL TO PROVIDE AN ESTIMATE OF PROGNOSIS (AGGRESSIVENESS OF DISEASE) OF B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA (B-CLL) AND TO HELP EVALUATE TREATMENT OPTIONS. B-CLL WITH MUTATED (>2% MUTATION) IGVH IS TYPICALLY LESS AGGRESSIVE (MORE SLOWLY PROGRESSIVE) THAN B-CLL WITH UNMUTATED (<2%) IGVH.
Why book with us?
Free and On Schedule Sample Collection
24/7 Service
Affordable
Quick and Accurate Reports
4 ML (2 ML MIN.) WHOLE BLOOD IN 1 LAVENDER TOP (EDTA) TUBE. SHIP REFRIGERATED. DO NOT FREEZE.